The new research portal will provide visitors with unparalleled access
to company research on NanoBio
Corporation, alongside comprehensive market research on their
position within the global pharmaceutical industry.
NanoBio is a featured company in the Global
Influenza Market report. This report is designed to be a helpful
business tool that provides a thorough evaluation of the market for
influenza vaccines, therapeutics and diagnostics. It provides
information about products available, products in development, issues
and trends influencing the market, and competitive analysis of top
providers, with a special emphasis on U.S. and European markets.
According to the report, the market is expected to increase from $5.4
Billion in 2016 to $6.4 billion in 2021 at a CAGR of 3.6%.
“NanoBio is a leading player within the global influenza market and the
new portal provides easy access to information on their performance as a
company and their impact on the overall pharma industry,” says Ross
Glover, CEO of Research and Markets.
For more information visit: http://www.researchandmarkets.com/companies/nanobio-corporation?cid=gf7zqk
About Research and Markets
Research and Markets is the world's leading market research store.
With more than 1.5 million research resources, we deliver the largest
collection of business information products on the market. We offer the
most in-depth market analysis across a multitude of industries. Our
products provide clients with an unrivalled understanding of their
chosen market. No matter how specialist your field, we have the insights
and market data to help you make efficient and effective decisions.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170421005560/en/
Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.comFor
E.S.T. Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call
1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S.
Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716